Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts

Digestive Diseases and Sciences

Volumn 42, Issue 7, 1997, Pages 1486-1488

  Mallat, Ariane ^a   Zafrani, Elie Serge ^a   Metreau, Jean Michel ^a   Dhumeaux, Daniel ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Cholestasis; Drug toxicity; Hepatitis; Interlobular bile ducts; Terbinafine

Indexed keywords

ALANINE AMINOTRANSFERASE; TERBINAFINE;

AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILE DUCT; CASE REPORT; CHOLESTASIS; CHOLESTATIC HEPATITIS; DRUG INDUCED DISEASE; FEMALE; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER TOXICITY; PRIORITY JOURNAL; PRURITUS;

AGED; ANTIFUNGAL AGENTS; BILE DUCTS, INTRAHEPATIC; CANDIDIASIS, CUTANEOUS; CHOLESTASIS, INTRAHEPATIC; FEMALE; HEPATITIS, TOXIC; HUMANS; NAPHTHALENES;

EID: 0030810962     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018870828038     Document Type: Article

References (22)

1. Balfour JA, Faulds D: Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 43:259-284, 1942
2. Finlay AY: Global overview of Lamisil. Br J Dermatol 130(suppl 43):1-3, 1994
3. Kovacs MJ, Alshammari S, Guenther L, Bourcier M: Neutropenia and pancytopenia associated with oral terbinafine. J Am Acad Dermatol 31:806, 1994
4. Juhlin L: Loss of taste and terbinafine. Lancet 339:1483, 1992
5. Rzany B, Mockenhaupt M, Gehring W, Schöpf E: Stevens-Johnson syndrome after terbinafine therapy. J Am Acad Dermatol 30:509, 1994
6. Mc Gregor JM, Rustin MHA: Terbinafine and erythema multiforme. Br J Dermatol 131:587-588, 1994
7. Lowe G, Green C, Jennings P: Hepatitis associated with terbinafine treatment. Br Med J 306:248, 1993
8. van't Wout JW, Herrmann WA, De Vries RA, Stricker BHC: Terbinafine-associated hepatic injury. J Hepatol 21:115-117, 1994
9. Lazaros GA, Papatheodoridis GV, Delladetsima JK, Tassopoulos NC: Terbinafine-induced cholestatic liver disease. J Hepatol 24:753-756, 1996
10. Vantaux P, Grasset D, Nougue J, Lagier E, Seigneuric C: Hépatite aiguë en rapport avec la prise de terbinafine. Gastroenterol Clin Biol 20:402-403, 1996
11. Danan G: Consensus meetings on: causality assessment of drug-induced liver injury. J Hepatol 7:132-136, 1988
12. Zafrani ES, Degott C: Maladies non tumorales des voies biliaires intrahépatiques de l'adulte. Ann Pathol 15:348-356, 1995
13. Sherlock S: The syndrome of disappearing intrahepatic bile ducts. Lancet 2:493-496, 1987
14. Hay RJ: Risk/benefit ratio of modern antifungal therapy: Focus on hepatic reactions. J Am Acad Dermatol 29:S50-S54, 1993
15. Ishak KG, Sharp HL: Developmental abnormalities and liver disease in childhood. In Pathology of the Liver. RMN Mac Sween, PP Anthony, PJ Scheuer, AD Buret, BC Portmann (eds). Edinburgh, Churchill Livingstone, 1994, pp 83-122
16. Larrey D, Erlinger S: Drug-induced cholestasis. Bailliere's Clin Gastroenterol 2:423-452, 1988
17. Ishak KG, Irey NS: Hepatic injury associated with the phenothiazines. Clinicopathologic and follow-up study of 36 patients. Arch Pathol 93:283-304, 1972
18. Larrey D, Pessayre D, Duhamel G, Casier A, Degott C, Feldmann G, Erlinger S, Benhamou J-P: Prolonged cholestasis after ajmaline-induced acute hepatitis. J Hepatol 2:81-87, 1986
19. Larrey D, Amouyal G, Degott C, Danne O, Machayekhi JP, Feldmann G, Benhamou JP: Amitriptyline-induced prolonged cholestasis. Gastroenterology 94:200-203, 1988
20. Hunt CM, Washington K: Tetracydine-induced bile duct paucity and prolonged cholestasis. Gastroenterology 107:1844-1847, 1994
21. Degott C, Feldmann G, Larrey D, Durand-Schneider AM, Grange D, Machayekhi JP: Drug-induced prolonged cholestasis in adults: A histological semiquantitative study demonstrating progressive ductopenia. Hepatology 15:244-251, 1992
22. Jensen JC: Clinical pharmacokinetics of terbinafine (Lamisil®). Clin Exp Dermatol 14:110-113, 1989